BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Kinex Pharmaceuticals 

1207 Delaware Avenue

Buffalo  New York  14209  U.S.A.
Phone: 716-332-6107 Fax: 716-332-6170


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Kinex Pharmaceuticals Appoints Chief Operating Officer 12/17/2014 9:12:10 AM
Hanmi Pharmaceutical, Co., Ltd And Collaborative Partner Kinex Pharmaceuticals Announce Preliminary Results From A Phase I Clinical Study (HM-OTE-103) With Oratecan® In Patients With Advanced Cancer 10/15/2014 7:56:26 AM
Kinex Pharmaceuticals Completes Acquisition Of QuaDPharma 9/9/2014 7:42:00 AM
Kinex Pharmaceuticals Announces Allowance Of The Investigational New Drug (IND) Application For KX2-391 Ointment By The United States FDA 7/24/2014 11:04:31 AM
Kinex Pharmaceuticals Appoints Mr. Michael Murphy To The Board Of Directors 7/1/2014 11:50:30 AM
Hanmi Pharmaceutical, Co., Ltd And Collaborative Partner Kinex Pharmaceuticals Report Encouraging Results On Oraxol® For Patients With Advanced Gastric Cancer From A Phase I/II Clinical Study 6/30/2014 9:05:33 AM
Kinex Pharmaceuticals Announces Key Additions To Clinical Leadership Team In Newly Formed Clinical Development Office In Cranford, New Jersey 5/13/2014 9:40:40 AM
Kinex Pharmaceuticals Receives FDA Allowance For Oratecan, An Oral Form Of Irinotecan With Enhanced Gastrointestinal Absorption, The Second U.S. IND Based On The Orascovery Technology Platform 5/5/2014 8:52:50 AM
Kinex Pharmaceuticals And Zenith Technology To Initiate Clinical Studies Of An Oral Form Of Paclitaxel (Oraxol) In New Zealand 3/20/2014 10:32:47 AM
Kinex Pharmaceuticals Completes Oversubscribed $40 Million Private Placement Equity Raise 3/5/2014 6:07:59 AM
12345